海南海药股价微跌0.91% 氟非尼酮进入III期临床试验阶段

Company Overview - Hainan Haiyao's stock price closed at 6.50 yuan on August 5, down 0.06 yuan, a decrease of 0.91% from the previous trading day [1] - The trading volume on that day was 413,556 hands, with a transaction amount of 269 million yuan [1] - The stock price fluctuated between 6.44 yuan and 6.60 yuan, with a volatility of 2.44% [1] Business Operations - Hainan Haiyao operates in the pharmaceutical manufacturing industry, focusing on drug research, production, and sales [1] - The company's product line includes antibiotics, anti-tumor drugs, and cardiovascular medications across various therapeutic areas [1] - The company is registered in Haikou City, Hainan Province [1] Clinical Development - On August 5, the company announced on an interactive platform that its innovative drug, Fluorofenone, requires Phase III clinical trials, with the specific launch date to be determined based on the progress of these trials [1] Shareholder Information - As of July 31, the total number of shareholders was 87,580, an increase of 17,700 from July 20 [1] - The number of shares held by the Shenzhen Stock Connect remained at 7.7945 million shares, accounting for 0.60% of the circulating share capital [1] Capital Flow - On August 5, the net outflow of main funds was 29.6253 million yuan, representing 0.39% of the circulating market value [1] - Over the past five trading days, the cumulative net outflow reached 59.3909 million yuan, accounting for 0.78% of the circulating market value [1]